ArticleInternational journal of general medicine2021

Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study.

Hong-Tao Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.